Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;13(2):759-765.
doi: 10.3892/etm.2016.3984. Epub 2016 Dec 19.

Role of microRNA-130a in myocardial hypoxia/reoxygenation injury

Affiliations

Role of microRNA-130a in myocardial hypoxia/reoxygenation injury

Hongyan Liu et al. Exp Ther Med. 2017 Feb.

Abstract

The aim of this study was to investigate the role of microRNA (miR)-130a in the pathogenesis of myocardial hypoxia/reoxygenation (H/R) injury. Primary rat cardiomyocytes were cultured and subjected to H/R treatment. Reverse transcription-quantitative polymerase chain reaction was performed to detect the levels of miR-130a, western blot analysis was used to determine the expression of various proteins, and CCK-8 assay was performed to determine cell viability. In addition, flow cytometry was used to assess apoptosis. The cell viability was significantly decreased and the apoptosis rate was significantly increased in H/R-treated primary cardiomyocytes, and the expression level of miR-130a was also elevated in these model cells. Transfection with miR-130a inhibitor significantly elevated the cell viability and reduced the apoptosis rate in H/R-treated cardiomyocytes. Bioinformatics analysis indicated that autophagy-related gene 14 (ATG14) is the target for miR-130a, which was confirmed by dual-luciferase reporter assay and western blot analysis. When the H/R model cells were co-transfected with miR-130a inhibitor and small interfering RNA against ATG14, the cell viability was significantly reduced and the apoptosis rate was significantly elevated, compared with that of cells transfected with miR-130a inhibitor alone. miR-130a inhibitor transfection significantly elevated the levels of ATG14 and phosphorylated (p-)Beclin 1, increased the LC3II/LC3I ratio, and decreased the expression levels of P62 and cleaved caspase-3, while the co-transfection of miR-130a inhibitor and siR-ATG14 attenuated these effects in H/R-induced primary cardiomyocytes. These results indicate that miR-130a is involved in H/R-induced injuries in primary cardiomyocytes, and that the inhibition of miR-130a increases the levels of ATG14 and p-Beclin 1, thereby increasing autophagy and inhibiting apoptosis in these cells.

Keywords: apoptosis; autophagy; autophagy-related gene 14; hypoxia/reoxygenation; miR–130a; microRNA.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Involvement of miR–130a in H/R-induced injuries in primary cardiomyocytes. (A) Cell viability and (B) apoptosis of H/R-induced cardiomyocytes transfected with 100 nM miR–130a inhibitor were assessed. (C) The expression level of miR–130a in H/R-induced cardiomyocytes was detected using RT-qPCR. (D) Primary cardiomyocytes were transfected with miR–130a inhibitor at 25, 50, and 100 nM, respectively, and RT-qPCR was performed to detect the expression levels of miR–130a in these cells. (E) Representative results for the flow cytometry to detect apoptosis. **P<0.01 vs. the normal control group; #P<0.05 vs. H/R-induced model cells. miR, microRNA; H/R, hypoxia/reoxygenation; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; NC, negative control; inh, inhibitor.
Figure 2.
Figure 2.
Interaction between miR–130a and ATG14. (A) Prediction of miR–130a target gene with TargetScan software. (B) Dual-luciferase reporter assay results showing the interaction between miR–130a and ATG14. (C) The expression levels of ATG14 as detected by western blot analysis. *P<0.01 vs. the NC group. miR, microRNA; ATG14, autophagy-related gene 14; UTR, untranslated region; wt, wild type; mut, mutant; NC, negative control.
Figure 3.
Figure 3.
Effects of ATG14 interference on cell viability and apoptosis in H/R-induced primary cardiomyocytes. (A) Primary cardiomyocytes were transfected with siR-ATG14 at 25, 50, and 100 nM, respectively, and the mRNA expression levels of ATG14 were detected with RT-qPCR. The H/R-induced primary cardiomyocytes were co-transfected with miR–130a inhibitor and siR-ATG14, and then (B) the cell viability and (C) apoptosis were assessed using CCK-8 assay and flow cytometry, respectively. (D) Representative results for the flow cytometric detection of apoptosis. **P<0.01 vs. the NC group; #P<0.05 vs. the H/R-induced model cells; &P<0.05 vs. the H/R models treated with miR–130a inhibitor. ATG14, autophagy-related gene 14; H/R, hypoxia/reoxygenation; RT-qPCR, reverse transcription-quantitative polymerase chain reaction; siR, small interfering RNA; NC, negative control; inh, inhibitor.
Figure 4.
Figure 4.
Effects of miR–130a inhibition on autophagy and apoptosis in H/R-induced primary cardiomyocytes. Western blot analysis was performed to detect the expression levels of ATG14, p-Beclin 1, LC3, P62 and c-CASP3 in the H/R-induced primary cardiomyocytes transfected with miR–130a inhibitor and/or siR-ATG14. miR, microRNA; H/R, hypoxia/reoxygenation; ATG14, autophagy-related gene 14; p-Beclin 1, phosphorylated Beclin 1; c-CASP3, cleaved caspase-3; inh, inhibitor.

References

    1. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159–173. doi: 10.1161/CIRCRESAHA.111.243162. - DOI - PMC - PubMed
    1. Przyklenk K, Undyala VV, Wider J, SalaMercado JA, Gottlieb RA, Mentzer RM., Jr Acute induction of autophagy as a novel strategy for cardioprotection: Getting to the heart of the matter. Autophagy. 2011;7:432–433. doi: 10.4161/auto.7.4.14395. - DOI - PMC - PubMed
    1. Yue HW, Liu J, Liu PP, Li WJ, Chang F, Miao JY, Zhao J. Sphingosylphosphorylcholine protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy. Biochim Biophys Acta. 2015;1851:1186–1193. doi: 10.1016/j.bbalip.2015.04.001. - DOI - PubMed
    1. He XM, Zheng YQ, Liu SZ, Liu Y, He YZ, Zhou XY. Altered Plasma MicroRNAs as Novel Biomarkers for Arteriosclerosis Obliterans. J Atheroscler Thromb. 2016;23:196–206. doi: 10.5551/jat.30775. - DOI - PubMed
    1. Kim GH, Samant SA, Earley JU, Svensson EC. Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One. 2009;4:e6161. doi: 10.1371/journal.pone.0006161. - DOI - PMC - PubMed